Black Rock Inc. Design Therapeutics, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DSGN
# of Institutions
101Shares Held
33.4MCall Options Held
4KPut Options Held
3.1K-
Sr One Capital Management, LP6.53MShares$25.3 Million11.4% of portfolio
-
Logos Global Management LP San Francisco, CA4.22MShares$16.3 Million3.17% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.95MShares$7.56 Million0.47% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.82MShares$7.04 Million0.02% of portfolio
-
Baker Bros. Advisors LP New York, NY1.74MShares$6.75 Million0.08% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $216M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...